Can autoimmune or other non‑malignant diseases cause lymph nodes to become enlarged, rounded, and lose the fatty hilum on imaging?

Can Autoimmune or Non-Malignant Diseases Cause Enlarged, Rounded Lymph Nodes with Loss of Fatty Hilum?

Yes, autoimmune and non-malignant diseases can absolutely cause lymph nodes to become enlarged, rounded, and lose their fatty hilum on imaging—these features are NOT specific to malignancy despite being commonly associated with it.

Key Evidence from Guidelines

The most recent and comprehensive guideline evidence demonstrates that loss of fatty hilum, rounded shape, and enlargement are frequently seen in benign conditions 1. The 2018 ACR white paper explicitly states that enlarged mediastinal lymph nodes (>1 cm) have been described in association with numerous non-malignant diseases including:

• Granulomatous diseases (sarcoidosis being the most common)
• Autoimmune conditions (rheumatoid arthritis, systemic lupus erythematosus)
• Congestive heart failure (enlarged nodes >2 cm can occur)
• Interstitial lung diseases (multiple types including collagen vascular disease)
• Immunoglobulin G4-related disease
• Infections (pneumonia, tuberculosis, other thoracic infections)

1

Critical Nuance: These Features Are NOT Specific

While the 2011 thyroid cancer guidelines note that 65.6-85% of malignant lymph nodes are rounded with loss of fatty hilum 2, the critical finding is that 9-73% of normal lymph nodes may not have a visible hilum 2. This means absence of hilum has only 29-35% specificity for malignancy—it is a sensitive but non-specific finding 2.

Research Evidence Confirms Benign Causes

A 2015 study of 73 patients with suspicious-appearing axillary lymph nodes (showing loss of fatty hilum in 79.5%, rounded shape in 75.3%, and abnormal cortical thickening in 82.1%) found that none had malignancy—all were benign reactive hyperplasia, Kikuchi disease, tuberculosis, or sarcoidosis 3. This demonstrates that extremely suspicious morphologic features can occur in entirely benign conditions.

Specific Autoimmune Diseases That Cause These Features

The 2020 ATS sarcoidosis guideline confirms that sarcoidosis commonly presents with bilateral hilar lymphadenopathy and was confirmed in 85% of patients with this imaging pattern 4. The 2004 lymphoma pathology guideline specifically lists autoimmune disease as pertinent clinical information when evaluating lymphadenopathy 5.

Additional autoimmune causes documented in recent literature include:

• Rheumatoid arthritis 1, 6
• Systemic lupus erythematosus 1, 6
• IgG4-related disease 6
• Castleman disease 6
• Kawasaki disease 6

Clinical Approach Algorithm

When encountering enlarged, rounded lymph nodes with loss of fatty hilum:

1. Assess clinical context first:

   • Known autoimmune disease? → Likely reactive
   • Recent vaccination (especially COVID-19)? → Vaccine-related adenopathy 7, 6
   • Symptoms of infection or inflammation? → Infectious/inflammatory cause
   • Constitutional symptoms (fever, night sweats, weight loss)? → Requires further workup

2. Evaluate additional imaging features:

   • Bilateral hilar pattern → Strongly suggests sarcoidosis (85% probability) 4
   • Microcalcifications or cystic changes → More specific for malignancy 2
   • Preserved hilar vascularity on Doppler → Favors benign (even if hilum not visible on B-mode) 2
   • Associated findings (interstitial lung disease, heart failure, other organ involvement) → Points to systemic non-malignant cause 1

3. Size thresholds matter:

   • Nodes ≤15 mm in short axis are more likely benign 1
   • Nodes >25 mm warrant higher suspicion 1

4. Follow-up strategy for indeterminate cases:

   • No known malignancy + no symptoms → Short-term imaging follow-up (3-6 months) is reasonable rather than immediate biopsy 3
   • Known cancer history → Lower threshold for biopsy
   • Progressive enlargement → Requires tissue diagnosis

Common Pitfalls to Avoid

• Do not assume rounded shape + loss of hilum = malignancy. These features have poor specificity (29-35%) 2
• Do not ignore clinical context. A patient with known rheumatoid arthritis and new lymphadenopathy likely has reactive nodes, not cancer
• Do not forget iatrogenic causes. COVID-19 vaccination causes ipsilateral axillary adenopathy in up to 16% of patients 7
• Do not overlook bilateral hilar pattern. This is almost always sarcoidosis in asymptomatic patients 4

In patients without known malignancy and suspicious-appearing nodes, short-term imaging follow-up is often more appropriate than immediate biopsy, as the majority will prove benign 3.